Related Experiment Video
Updated: Jul 6, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
Immunotherapy of hematological malignancies using dendritic cells
Ann L R Van de Velde1, Zwi N Berneman, Viggo F I Van Tendeloo
1Centre for Cellular Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium. vigor.vantendeloo@ua.ac.be
Bulletin Du Cancer
|April 9, 2008
Summary
Dendritic cell (DC) vaccines show promise in treating blood cancers by stimulating the immune system. Further research and clinical trials are needed to confirm their value in hematological oncology.
Area of Science:
- Immunology
- Oncology
- Cancer Immunotherapy
Background:
- The treatment of hematological malignancies is evolving with advancements in tumor immunobiology.
- Manipulating the immune system offers strategies to overcome tumor-induced immunosuppression.
- Active specific immunotherapy, particularly dendritic cell (DC)-based vaccines, is a key area of interest.
Purpose of the Study:
- To provide a comprehensive review and update on the application of dendritic cells (DCs) in treating hematological malignancies.
- To highlight the potential of DC-based vaccines as a therapeutic strategy.
Main Methods:
- Review of current research and clinical applications of dendritic cells in hematological cancers.
- Synopsis of how DCs function as cellular adjuvants to enhance anti-tumor immunity.
Main Results:
- Dendritic cells are being investigated for their ability to augment tumor-specific CD8+ cytotoxic T lymphocytes.
- DC-based vaccines aim to harness the immune system to fight hematological malignancies.
Conclusions:
- Dendritic cell vaccination represents a promising adjuvant therapy for hematological oncology.
- Further basic research and clinical trials are essential to fully establish the efficacy of DC vaccination.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...